Company profile for Heat Biologics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Heat Biologics is a biopharmaceutical company that is developing immunotherapies to activate a patient's immune system against cancer. Our drugs are designed to take advantage of a natural biological process to robustly activate & stimulate T-cells to turn COLD Tumors HOT. Heat Biologics is an immuno-oncology company developing breakthrough therapies based on our T-cell Activation Platform designed to activate “killer” T-c...
Heat Biologics is a biopharmaceutical company that is developing immunotherapies to activate a patient's immune system against cancer. Our drugs are designed to take advantage of a natural biological process to robustly activate & stimulate T-cells to turn COLD Tumors HOT. Heat Biologics is an immuno-oncology company developing breakthrough therapies based on our T-cell Activation Platform designed to activate “killer” T-cells, to destroy a patient’s cancer. Heat’s drug candidates are designed to become an essential ingredient of the immuno-oncology cocktail to enhance the effectiveness of cancer therapies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
627 Davis Drive Suite 400 Morrisville, NC 27560
Telephone
Telephone
+1 919 240 7133
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2022/05/03/2434361/32418/en/Heat-Biologics-Completes-Name-Change-to-NightHawk-Biosciences-Trading-to-Commence-Under-NHWK-Effective-at-the-Market-Open-Today.html

GLOBENEWSWIRE
03 May 2022

https://endpts.com/nighthawk-flies-into-national-stockpile-deal-with-canadian-government-for-anthrax-drug/

Josh Sullivan ENDPTS
27 Apr 2022

https://www.globenewswire.com/news-release/2022/04/20/2425440/32418/en/Heat-Biologics-NightHawk-Biosciences-Completes-Acquisition-of-Elusys-Therapeutics.html

GLOBENEWSWIRE
20 Apr 2022

https://www.globenewswire.com/news-release/2022/04/19/2424737/32418/en/Heat-Biologics-Announces-Planned-Name-Change-to-NightHawk-Biosciences-Reflecting-Company-s-Evolution-Therapeutic-Pipeline-Expansion-Vertical-Integration-and-New-Biodefense-Capabili.html

GLOBENEWSWIRE
19 Apr 2022

https://www.globenewswire.com/news-release/2022/04/18/2423935/32418/en/REMINDER-Heat-Biologics-to-Host-Planned-Investor-and-Media-Livestream-Event-on-Tuesday-April-19th-at-10-30-AM-ET-to-Discuss-Latest-Developments.html

GLOBENEWSWIRE
18 Apr 2022

https://www.globenewswire.com/news-release/2022/04/18/2423711/32418/en/Heat-Biologics-Scorpion-Subsidiary-Announces-Planned-Development-of-New-Kansas-Commercial-Biodefense-Biomanufacturing-Facility.html

GLOBENEWSWIRE
18 Apr 2022

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty